Evidence map›Paper›PMID 36279312›Full record

ArticlePLoS biology2022

Phosphoinositide species and filamentous actin formation mediate engulfment by senescent tumor cells.

Wesley D Frey, Ashlyn Y Anderson, Hyemin Lee, Julie B Nguyen, Emma L Cowles, Hua Lu, James G Jackson

Abstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. The states of senescent cells.Biochemical Society transactions · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wesley D FreyTulane School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, Louisiana, United States of America.
Ashlyn Y AndersonTulane School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, Louisiana, United States of America.
Hyemin LeeTulane School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, Louisiana, United States of America.
Julie B NguyenTulane School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, Louisiana, United States of America.
Emma L CowlesTulane School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, Louisiana, United States of America.
Hua LuTulane School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, Louisiana, United States of America.
James G JacksonTulane School of Medicine, Department of Biochemistry and Molecular Biology, New Orleans, Louisiana, United States of America.ORCID 0000-0002-2640-6442

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leigh Lamonica · 2012 to 2026
$69.1M
Translational Genomics CoreP30GM114732 · NIGMS · LSU HEALTH SCIENCES CENTER · PI OCHOA, AUGUSTO C. · 2015 to 2019
$5.2M
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma MicrosamplesU01CA252965 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI HU, TONY Y., LU, HUA · 2020 to 2024
$3.0M
Targeting mechanisms of immune evasion in chemotherapy-induced senescent cellsR01CA259001 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI James Jackson · 2022 to 2026
$2.1M
The Role of p53-R249S’s GOF in HCC developmentR01CA234605 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2019 to 2023
$1.8M
Genotoxic stress response and mutagenesis in normal tissues of mice deficient in homology directed repairR01ES032036 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI JACKSON, JAMES · 2021 to 2025
$1.7M
Validating p53 Ser46 crotonylation as a potential target for possible anti-cancer therapyR21CA272890 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2022 to 2023
$388k
NCI NIH HHS R01 CA234605NCI NIH HHS R01 CA259001NCI NIH HHS R21 CA272890NCI NIH HHS U01 CA252965NIEHS NIH HHS R01 ES032036NIGMS NIH HHS P30 GM114732NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Cancer cells survive chemotherapy and cause lethal relapse by entering a senescent state that facilitates expression of many phagocytosis/macrophage-related genes that engender a novel cannibalism phenotype. We used biosensors and live-cell imaging to reveal the basic steps and mechanisms of engulfment by senescent human and mouse tumor cells. We show filamentous actin in predator cells was localized to the prey cell throughout the process of engulfment. Biosensors to various phosphoinositide (PI) species revealed increased concentration and distinct localization of predator PI(4) P and PI(4,5)P2 at the prey cell during early stages of engulfment, followed by a transient burst of PI(3) P before and following internalization. PIK3C2B, the kinase responsible for generating PI(3)P, was required for complete engulfment. Inhibition or knockdown of Clathrin, known to associate with PIK3C2B and PI(4,5)P2, severely impaired engulfment. In sum, our data reveal the most fundamental cellular processes of senescent cell engulfment, including the precise localizations and dynamics of actin and PI species throughout the entire process.

Indexed as

Actin CytoskeletonActinsAnimalsHumansMicePhagocytosisPhosphatidylinositol PhosphatesActinsphosphatidylinositol 3-phosphatePhosphatidylinositol Phosphates

Identifiers

PMID36279312
PMCPMC9632905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.